Risk of combining PPIs with thienopyridines: fact or fiction?
Sibbing
Dirk
D
Deutsches Herzzentrum München und 1 Medizinische Klinik rechts der Isar, Technische Universität München, 80636 Munich, Germany. Electronic address: dirk@sibbing.net.
Kastrati
Adnan
A
Deutsches Herzzentrum München und 1 Medizinische Klinik rechts der Isar, Technische Universität München, 80636 Munich, Germany.
D001711:Biotransformation; D000077144:Clopidogrel; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D010879:Piperazines / Q000009:adverse effects* / Q000737:chemistry / Q000378:metabolism; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000737:chemistry / Q000378:metabolism; D000068799:Prasugrel Hydrochloride; D054328:Proton Pump Inhibitors / Q000009:adverse effects* / Q000378:metabolism; D011725:Pyridines / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism; D013876:Thiophenes / Q000009:adverse effects* / Q000737:chemistry / Q000378:metabolism; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism
D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D011725:Pyridines; D013876:Thiophenes; C446540:thienopyridine; D003577:Cytochrome P-450 Enzyme System; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine